Prescription Required
Formulation: Tablet
(Brand Option)
Select the prescribed dosage
Select the quantity to see the price.
Prescription Required
Formulation: Tablet
Select the quantity to see the price.
* This price includes a dispensing fee, medical review fee, and packing fee.
Shipped and delivered directly to your doorstep
Steglatro contains the active ingredient ertugliflozin. It is a prescription medication used to help improve blood sugar control in adults with type 2 diabetes mellitus.
Steglatro is used along with a healthy diet and regular physical activity to help lower blood glucose levels. It may be prescribed alone or together with other diabetes medications when additional blood sugar control is needed.
Steglatro does not treat type 1 diabetes and should not be used to treat diabetic ketoacidosis (DKA), a serious condition caused by a buildup of acids called ketones in the blood.
Steglatro is used to improve glycemic control, which means helping maintain healthier blood sugar levels, in adults with type 2 diabetes.
Type 2 diabetes occurs when the body does not use insulin properly or does not produce enough insulin to keep blood glucose levels within a normal range. Over time, high blood sugar levels can increase the risk of complications affecting the heart, kidneys, nerves, eyes, and blood vessels.
By helping lower blood sugar, Steglatro may be part of a broader diabetes management plan that includes:
Steglatro belongs to a class of medications called sodium-glucose co-transporter 2 (SGLT2) inhibitors.
SGLT2 is a protein in the kidneys that normally helps return glucose from the urine back into the bloodstream. Steglatro blocks this protein, allowing more glucose to leave the body through urine.
By increasing the amount of glucose removed by the kidneys, Steglatro helps lower blood sugar levels.
When used as prescribed, Steglatro may help:
Steglatro works best when combined with lifestyle changes recommended by your healthcare provider, including healthy eating and regular physical activity.
Steglatro is not a substitute for diet and exercise. Continue following your diabetes management plan and attend regular appointments with your healthcare provider.
Your healthcare provider may monitor your blood sugar levels, kidney function, and overall response to treatment to ensure Steglatro remains safe and effective for you.
Contact your healthcare provider if you experience symptoms of dehydration, urinary tract infection, genital infection, severe nausea, vomiting, abdominal pain, unusual tiredness, or signs of ketoacidosis.
Steglatro contains ertugliflozin and is available as a tablet taken by mouth. It is usually taken once daily in the morning, with or without food, as directed by your healthcare provider.
Take Steglatro at the same time each day to help maintain consistent blood sugar control. Swallow the tablet whole with water and follow all instructions provided by your healthcare provider and pharmacist.
The dose you receive will depend on your medical condition, kidney function, other diabetes medications you take, and how well your blood sugar responds to treatment.
The usual starting dose of Steglatro is 5 mg once daily in the morning, taken with or without food.
If additional blood sugar control is needed and the medication is well tolerated, your healthcare provider may increase the dose to 15 mg once daily, which is the maximum recommended daily dose.
Your healthcare provider may adjust your dose based on:
Do not increase, decrease, or stop taking Steglatro without first speaking with your healthcare provider.
Take Steglatro regularly, even if you feel well.
Do not take more than your prescribed dose.
If you miss a dose, take it as soon as you remember unless it is close to your next scheduled dose. Do not take two doses at the same time to make up for a missed dose.
Continue following your recommended diet, exercise plan, and diabetes monitoring schedule while taking Steglatro.
Your healthcare provider will monitor your response to treatment and may check your blood sugar levels and kidney function regularly to ensure Steglatro remains safe and effective for you.
Steglatro (Ertugliflozin) is available in the following forms and strengths:
Steglatro can increase urination by helping your body remove excess glucose through the urine. This may cause fluid loss and dehydration, which can lead to dizziness, lightheadedness, fainting, or a drop in blood pressure.
The risk may be higher if you are older, take diuretics (water pills), have kidney problems, or do not drink enough fluids.
Drink adequate fluids as recommended by your healthcare provider. Contact your healthcare provider if you experience signs of dehydration, such as extreme thirst, dry mouth, weakness, dizziness, or fainting.
There is limited information about the safety of Steglatro during pregnancy.
Because Steglatro may affect kidney development in an unborn baby, especially during the second and third trimesters, your healthcare provider will determine whether the potential benefits outweigh the possible risks.
Tell your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding before starting Steglatro or during treatment. (accessdata.fda.gov)
Steglatro alone does not usually cause low blood sugar. However, the risk of hypoglycemia may increase when Steglatro is taken with other diabetes medications, especially insulin or sulfonylureas.
Symptoms of low blood sugar may include:
Talk to your healthcare provider about how to recognize and manage low blood sugar. Your medication doses may need adjustment if hypoglycemia occurs.
Steglatro affects how the kidneys remove glucose from the body. Your healthcare provider will assess your kidney function before starting treatment and may monitor it during treatment.
Steglatro is not recommended for certain patients with severely reduced kidney function because it may not work effectively and may increase the risk of complications.
Tell your healthcare provider if you have kidney disease, a history of kidney problems, or conditions that may affect kidney function.
In clinical studies, SGLT2 inhibitors have been associated with an increased risk of lower limb amputation, although the overall risk is uncommon.
The risk may be higher in people with factors such as:
Check your feet regularly and report any new pain, tenderness, sores, ulcers, skin colour changes, or infections to your healthcare provider promptly.
Seek medical advice if you develop any foot wound or infection, as early treatment may help prevent complications.
Before taking Steglatro, tell your healthcare provider about all medical conditions, medications, vitamins, and supplements you use.
Seek medical attention immediately if you develop symptoms such as severe nausea, vomiting, abdominal pain, unusual tiredness, difficulty breathing, confusion, or signs of a serious infection, as these may require urgent evaluation.
No. Steglatro is not approved for use in people with type 1 diabetes. Using Steglatro in people with type 1 diabetes may increase the risk of a serious condition called diabetic ketoacidosis (DKA), which occurs when the body produces high levels of ketones that can make the blood too acidic. Steglatro is intended for adults with type 2 diabetes as an addition to diet and exercise to help improve blood sugar control.
Yes. Steglatro may be used together with other diabetes medications when additional blood sugar control is needed. It may be prescribed alongside medications such as metformin, insulin, sulfonylureas, or other glucose-lowering treatments as part of a personalized diabetes management plan. When Steglatro is combined with insulin or certain medications that increase insulin release, the risk of low blood sugar (hypoglycemia) may be higher. Your healthcare provider may adjust the doses of your other diabetes medications to help reduce this risk and maintain safe blood sugar levels. Always inform your healthcare provider about all prescription medications, over-the-counter products, vitamins, supplements, and herbal products you are taking before starting Steglatro. This helps ensure your treatment plan is safe and appropriate for your individual needs.
Steglatro begins working soon after the first dose by helping the kidneys remove glucose from the bloodstream through urine. Blood sugar levels may begin to decrease within hours after taking the medication, but the full effect on long-term blood sugar control may take several weeks of regular use. Continue taking Steglatro as prescribed, even if you do not notice immediate changes in how you feel. Your healthcare provider will monitor your blood sugar levels to determine how well the medication is working.
Steglatro can be taken with or without food. Food does not significantly affect how the medication is absorbed, so you can take it with meals or on an empty stomach. It is usually taken once daily in the morning at the same time each day. Drink enough fluids while taking Steglatro to help prevent dehydration, especially if you experience increased urination, hot weather, illness, or fluid loss. Follow your healthcare provider’s instructions regarding fluid intake and diabetes management.
| Generic name: | Ertugliflozin |
|---|---|
| Formulation: | Tablet |
| Strength(s): | 5mg, 15mg |
| Quantities Available: | 28, 56, 84, 280 |
Our online Canadian Pharmacy is known for high standards of quality, safety, and efficiency when it comes to medications.
Our pharmacy offers lower prices on prescription drugs compared to traditional pharmacies.
When ordering Steglatro (ertugliflozin) from a Canadian pharmacy, you can typically purchase up to a 90-day supply at one time, which is common for prescription medications to ensure adequate management of chronic conditions without frequent refills.
Here’s what you need to know:
Dosage and Quantity: Steglatro is commonly prescribed in dosages of 5 mg or 15 mg taken once daily. For a 90-day supply, you would order 90 tablets (90 days x 1 tablet per day).
No, we do not sell ertugliflozin directly. However, you can still enjoy competitive prices on Steglatro, which contains ertugliflozin as its active ingredient. To purchase Steglatro from our website, you will need a valid prescription from your healthcare provider. We require this to dispense the medication safely and in compliance with regulatory standards. You can conveniently submit your prescription by mailing it, faxing it, or uploading it through your online account on our website.
Yes, we ship Steglatro (ertugliflozin) to both the United States and Puerto Rico.
Watch how Online Pharmacies Canada is helping customers save money on their medications.
Online Pharmacies Canada has provided information from third parties intended to increase awareness and does not contain all the information about Steglatro (Ertugliflozin). Talk to your doctor or other qualified medical practitioners for medical attention or advice, or if you have any concerns about Steglatro (Ertugliflozin).
REVIEWS